Details for Patent: 9,321,807
✉ Email this page to a colleague
Which drugs does patent 9,321,807 protect, and when does it expire?
Patent 9,321,807 protects MAVYRET and is included in two NDAs.
Protection for MAVYRET has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fourteen patent family members in eight countries.
Summary for Patent: 9,321,807
| Title: | Crystal forms |
| Abstract: | The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in any one of FIGS. 1-4. |
| Inventor(s): | Shuang Chen, Bradley D. Gates, Ahmad Y. Sheikh |
| Assignee: | AbbVie Inc |
| Application Number: | US14/731,765 |
|
Patent Claim Types: see list of patent claims | Composition; Process; |
Drugs Protected by US Patent 9,321,807
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | MAVYRET | glecaprevir; pibrentasvir | PELLETS;ORAL | 215110-001 | Jun 10, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Abbvie | MAVYRET | glecaprevir; pibrentasvir | TABLET;ORAL | 209394-001 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,321,807
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015269306 | ⤷ Start Trial | |||
| Australia | 2020239679 | ⤷ Start Trial | |||
| Canada | 2948902 | ⤷ Start Trial | |||
| China | 106413736 | ⤷ Start Trial | |||
| Denmark | 4403223 | ⤷ Start Trial | |||
| European Patent Office | 3151850 | ⤷ Start Trial | |||
| European Patent Office | 4403223 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
